Literature DB >> 29113529

Pleuroparenchymal Fibroelastosis With Long History of Asbestos and Silicon Exposure.

Liyan Xu1, Negar Rassaei1, Carla Caruso1.   

Abstract

Pleuroparenchymal fibroelastosis (PPFE) is an uncommon interstitial lung disease. PPFE is characterized by fibroelastosis involving the pleura and subjacent parenchyma with a predominantly upper lobe distribution. While different possible environmental and familial etiologies have been postulated in the literature, the etiology of this disease remains essentially unclear and most cases are considered as idiopathic. In this report, we describe a rare case of PPFE with multiple lung lobe involvements and prolonged asbestos and silica exposure. Our goal is to investigate the exposure of asbestos and silica and try to identify their possible association with PPFE.

Entities:  

Keywords:  asbestos; injury; pleuroparenchymal fibroelastosis; silicon

Mesh:

Substances:

Year:  2017        PMID: 29113529     DOI: 10.1177/1066896917739399

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  3 in total

Review 1.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

Review 2.  Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.

Authors:  Felix Chua; Sujal R Desai; Andrew G Nicholson; Anand Devaraj; Elisabetta Renzoni; Alexandra Rice; Athol U Wells
Journal:  Ann Am Thorac Soc       Date:  2019-11

3.  Pleuroparenchymal Fibroelastosis with a Predominantly Airway-centered Distribution: A Late Complication of Chemotherapy.

Authors:  Kanako Katayama; Toru Arai; Takehiko Kobayashi; Sayoko Shintani; Naoko Takeuchi; Yoshinobu Matsuda; Chikatoshi Sugimoto; Yasushi Inoue; Maiko Takeda; Takahiko Kasai; Masanori Akira; Yoshikazu Inoue
Journal:  Intern Med       Date:  2022-02-15       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.